ApexOnco (@apexonco) 's Twitter Profile
ApexOnco

@apexonco

Oncology news and opinion.

ID: 3046218845

linkhttp://www.apexonco.com calendar_today20-02-2015 09:26:58

943 Tweet

1,1K Followers

123 Following

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

$NUVL tries to match $NUVB, but zidesamtinib has lost important ground in the front line. ApexOnco take on the Arros-1 update, plus filing plans -> oncologypipeline.com/apexonco/node/…

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

A new CDK2 degrader, plus $KYMR's return to oncology. Via ApexOnco -> oncologypipeline.com/apexonco/node/… $GILD $PFE $INCY $RHHBY $GLUE $BPMC

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

Heads up: a Claudin18.2 Car-T has just been filed for approval*. Via ApexOnco -> oncologypipeline.com/apexonco/node/… $ALMPF $LEGN $AZN *in China.

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

You already have a small-molecule inhibitor, so do you also need a degrader? $ONC $BGNE thinks yes, for BTK, CDK2 & Kras. Via ApexOnco -> oncologypipeline.com/apexonco/beone… $ARVN $GILD $RVMD

ApexOnco (@apexonco) 's Twitter Profile Photo

$AZN speeds puxitatug samrotecan into pivotal development oncologypipeline.com/apexonco/node/… $GSK $MRSN $ONC $BGNE

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

Zegfrovy gets its US approval, but don't expect an imminent launch. Via ApexOnco -> oncologypipeline.com/apexonco/node/… $CGEM $JNJ

Jacob Plieth (@jacobplieth) 's Twitter Profile Photo

Guess who's about to take a SC anti-PD-1 into phase 3? Via ApexOnco -> oncologypipeline.com/apexonco/node/… $ONC $BGNE $RHHBY $AZN $MRK $BMY $PFE